安科生物：子公司藥品注冊申請獲受理
作者：
2019-02-12 13:53來源：中國證券報·中證網
中證APP訊（記者 康曦）2月(yue)(yue)12日(ri)午間，安(an)(an)科生物（300009）公(gong)告稱，2019年2月(yue)(yue)11日(ri)，公(gong)司(si)全資子(zi)公(gong)司(si)安(an)(an)徽安(an)(an)科余良(liang)卿(qing)藥業有(you)限(xian)公(gong)司(si)（下稱：安(an)(an)科余良(liang)卿(qing)）收到(dao)國家(jia)藥品監督(du)管理局通(tong)知，公司申報的“活血止痛凝膠貼膏”臨(lin)床試(shi)驗申請已獲得(de)受(shou)理。
安科(ke)余(yu)(yu)良(liang)卿活(huo)血(xue)(xue)止(zhi)痛(tong)(tong)膏(gao)自(zi)1965年(nian)上市以來，已有五(wu)十余(yu)(yu)年(nian)的(de)臨(lin)(lin)床(chuang)應用(yong)(yong)歷(li)史，廣泛用(yong)(yong)于各種痹(bi)證。臨(lin)(lin)床(chuang)應用(yong)(yong)結(jie)果(guo)表明活(huo)血(xue)(xue)止(zhi)痛(tong)(tong)膏(gao)治(zhi)療(liao)痹(bi)癥或(huo)傷筋療(liao)效確切，尤其適用(yong)(yong)于寒濕型(xing)和血(xue)(xue)瘀型(xing)痹(bi)癥，已成(cheng)為治(zhi)療(liao)風濕痛(tong)(tong)和骨傷痛(tong)(tong)的(de)必備藥物。安科(ke)余(yu)(yu)良(liang)卿本次申報的(de)活(huo)血(xue)(xue)止(zhi)痛(tong)(tong)凝膠貼膏(gao)是(shi)在原活(huo)血(xue)(xue)止(zhi)痛(tong)(tong)膏(gao)基礎上開發的(de)新劑型(xing)，能(neng)夠明顯(xian)減少對給藥部位刺激反應，提高患者依(yi)從性(xing)，具(ju)有明顯(xian)的(de)臨(lin)(lin)床(chuang)優勢。
公司(si)表示，目(mu)前國內只(zhi)有活(huo)血止痛膏(gao)在(zai)臨床使用，尚無(wu)同品種(zhong)凝膠貼膏(gao)生產，因此，活(huo)血止痛凝膠貼膏(gao)的(de)開發上市將填補(bu)國內該(gai)品種(zhong)空白，具有良好(hao)的(de)社會效益(yi)和經(jing)濟效益(yi)。
公司同時提醒，本次獲得受(shou)理僅(jin)是新藥研發的階段性成果，后續能否獲得國(guo)家藥品監(jian)督管理局的批準進(jin)行臨床試驗、上市尚存在諸多不確定性，敬請廣大投(tou)資者注意(yi)投(tou)資風險。
中(zhong)(zhong)(zhong)(zhong)證(zheng)(zheng)網(wang)(wang)(wang)聲明(ming)(ming)：凡(fan)本(ben)網(wang)(wang)(wang)注(zhu)明(ming)(ming)“來源：中(zhong)(zhong)(zhong)(zhong)國證(zheng)(zheng)券(quan)(quan)報·中(zhong)(zhong)(zhong)(zhong)證(zheng)(zheng)網(wang)(wang)(wang)”的(de)所有作(zuo)品(pin)，版(ban)權(quan)均屬于中(zhong)(zhong)(zhong)(zhong)國證(zheng)(zheng)券(quan)(quan)報、中(zhong)(zhong)(zhong)(zhong)證(zheng)(zheng)網(wang)(wang)(wang)。中(zhong)(zhong)(zhong)(zhong)國證(zheng)(zheng)券(quan)(quan)報·中(zhong)(zhong)(zhong)(zhong)證(zheng)(zheng)網(wang)(wang)(wang)與作(zuo)品(pin)作(zuo)者(zhe)(zhe)聯合(he)聲明(ming)(ming)，任何組織未經(jing)中(zhong)(zhong)(zhong)(zhong)國證(zheng)(zheng)券(quan)(quan)報、中(zhong)(zhong)(zhong)(zhong)證(zheng)(zheng)網(wang)(wang)(wang)以及作(zuo)者(zhe)(zhe)書面授(shou)權(quan)不(bu)得(de)轉(zhuan)載、摘編或利用其它方(fang)式使(shi)用上述作(zuo)品(pin)。凡(fan)本(ben)網(wang)(wang)(wang)注(zhu)明(ming)(ming)來源非中(zhong)(zhong)(zhong)(zhong)國證(zheng)(zheng)券(quan)(quan)報·中(zhong)(zhong)(zhong)(zhong)證(zheng)(zheng)網(wang)(wang)(wang)的(de)作(zuo)品(pin)，均轉(zhuan)載自其它媒體，轉(zhuan)載目的(de)在于更好(hao)服務讀者(zhe)(zhe)、傳遞信息之需，并不(bu)代表本(ben)網(wang)(wang)(wang)贊同其觀(guan)點(dian)，本(ben)網(wang)(wang)(wang)亦不(bu)對其真(zhen)實(shi)性負責，持(chi)異(yi)議者(zhe)(zhe)應與原出(chu)處單(dan)位主張權(quan)利。
